Drug & Device Safety Atlas

FDA recall record · openFDA

LEICA BIOSYSTEMS NUSSLOCH GMBH

10 FDA recalls on record (2023–2025) — 10 device. 10 still ongoing.

0
Class I (most serious)
10
Class II
0
Class III
10
ongoing

How to read this. A recall count is not a quality verdict — large manufacturers recall more simply by volume, and a voluntary recall is the safety system working as intended. The signal to weight is the Class I count (the FDA's most-serious tier — reasonable probability of serious harm or death) and whether recalls are still ongoing. Most recalls are Class II/III. "Ongoing" reflects openFDA's last-published status — device recalls often stay marked ongoing long after they're resolved in practice; confirm current status at the FDA.

Most common reasons

As part of our post market surveillance, we recognized that some customers are using flammable freezing sprays within th 6
There is an issue regarding poorly processed and/or damaged biopsy tissue specimens on the HistoCore PEGASUS / HistoCore 1
Firm became aware of software issues related to most recent firmware update which could result in loss of patient tissue 1
Poorly processed and/or damaged biopsy tissue specimens on the device resulting from reagent levels exceeding the maximu 1
An issue with safe usage of the device was identified whereby toxic smoke and internal fire developed resulting from a p 1

Recalls

RECORDED — these are the FDA's published recall enforcement records (openFDA). Recalls are listed under the exact firm name as filed; a large manufacturer may also file under name variants, so this may not be the company's complete cross-variant record — confirm at the FDA recall database. This page informs and routes; it is not medical advice or a verdict on the company.

Machine-readable: JSON-LD · Markdown